Publications by authors named "Kate Zhong"

Claim this Profile
G
Globalization of Alzheimer's disease clinical trials: Current characteristics and future goals.
Jeffrey L Cummings, Josie Lindle, Ibrahim Dalla, Yadi Zhou, Kate Zhong

Int Psychogeriatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approach.
Jeffrey L Cummings, Kate Zhong, Clive Ballard, Mary Sano, Jacobo Mintzer

Int Psychogeriatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2025.
Jeffrey L Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Fonseca

Alzheimers Dement (N Y)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease.
Kate Zhong, Jeffrey Cummings

Expert Rev Neurother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.
Dawn C Matthews, Jefferson W Kinney, Aaron Ritter, Randolph D Andrews, Erin N Toledano Strom, Kate Zhong

Alzheimers Dement (N Y)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm.
Jeffrey Cummings, Mary Sano, Stefanie Auer, Sverre Bergh, Corinne E Fischer, Kate Zhong

Int Psychogeriatr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition.
Mary Sano, Jeffrey Cummings, Stefanie Auer, Sverre Bergh, Corinne E Fischer, Kate Zhong

Int Psychogeriatr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Jeffrey Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Fonseca

Alzheimers Dement (N Y)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2023.
Jeffrey Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Fonseca

Alzheimers Dement (N Y)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2022.
Jeffrey Cummings, Garam Lee, Pouyan Nahed, Mina Esmail Zadeh Nojoo Kambar, Kate Zhong

Alzheimers Dement (N Y)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2021.
Jeffrey Cummings, Garam Lee, Kate Zhong, Jorge Fonseca, Kazem Taghva

Alzheimers Dement (N Y)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia.
Dawn C Matthews, Aaron Ritter, Ronald G Thomas, Randolph D Andrews, Ana S Lukic, Kate Zhong

Alzheimers Dement (N Y)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition.
Jeffrey Cummings, Luiz Cortez Pinto, Manuel Cruz, Corinne E Fischer, Debby L Gerritsen, Kate Zhong

Am J Geriatr Psychiatry· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2020.
Jeffrey Cummings, Garam Lee, Aaron Ritter, Marwan Sabbagh, Kate Zhong

Alzheimers Dement (N Y)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2019.
Jeffrey Cummings, Garam Lee, Aaron Ritter, Marwan Sabbagh, Kate Zhong

Alzheimers Dement (N Y)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
Jeffrey Cummings, Aaron Ritter, Kate Zhong

J Alzheimers Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2018.
Jeffrey Cummings, Garam Lee, Aaron Ritter, Kate Zhong

Alzheimers Dement (N Y)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development pipeline: 2017.
Jeffrey Cummings, Garam Lee, Travis Mortsdorf, Aaron Ritter, Kate Zhong

Alzheimers Dement (N Y)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease.
Jeffrey L Cummings, Kate Zhong, Jefferson W Kinney, Chelcie Heaney, Joanne Moll-Tudla

Alzheimers Res Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.
Jeffrey Cummings, Jacobo Mintzer, Henry Brodaty, Mary Sano, Sube Banerjee, Kate Zhong

Int Psychogeriatr· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug-development pipeline: few candidates, frequent failures.
Jeffrey L Cummings, Travis Morstorf, Kate Zhong

Alzheimers Res Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cleveland Clinic Lou Ruvo Center for Brain Health: keeping memory alive.
Jeffrey Cummings, Kate Zhong, Charles Bernick

J Alzheimers Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Jeffrey L Cummings, Kate Zhong

Expert Rev Clin Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease drug development: translational neuroscience strategies.
Jeffrey L Cummings, Sarah J Banks, Ronald K Gary, Jefferson W Kinney, Joseph M Lombardo, Kate Zhong

CNS Spectr· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in designs for Alzheimer's disease clinical trials.
Jeffrey Cummings, Heath Gould, Kate Zhong

Am J Neurodegener Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis